Workflow
Gentherm(THRM)
icon
Search documents
Gentherm(THRM) - 2023 Q2 - Earnings Call Presentation
2023-08-01 16:00
Financial Performance - For the three months ended June 30, 2023, Gentherm's product revenues reached $372.323 million, compared to $260.715 million in 2022 [16] - Automotive product revenues for the three months ended June 30, 2023, were $361.533 million, up from $249.152 million in 2022 [16] - Adjusted EBITDA for the three months ended June 30, 2023, was $42.378 million, compared to $24.836 million in 2022, with an Adjusted EBITDA Margin of 11.4% versus 9.5% [16] - For the six months ended June 30, 2023, product revenues were $735.948 million, compared to $528.372 million in 2022 [16] - Adjusted EBITDA for the six months ended June 30, 2023, was $83.888 million, compared to $54.604 million in 2022, with an Adjusted EBITDA Margin of 11.4% versus 10.3% [16] - The company is excluding the impact of non-cash stock-based compensation in its calculation of Adjusted EBITDA Margin starting in 2023 [4] Business Highlights - Gentherm secured $670 million in new automotive business awards in the second quarter [13] - The company is strengthening its partnership with SourceMark Medical and expanding hospital accounts in China [15] - Gentherm anticipates product revenue between $1.45 billion and $1.55 billion for 2023 [18] - The company projects an Adjusted EBITDA Margin between 11.5% and 13.5% for 2023 [18]
Gentherm(THRM) - 2023 Q1 - Earnings Call Transcript
2023-04-29 05:14
Gentherm Incorporated (NASDAQ:THRM) Q1 2023 Earnings Conference Call April 27, 2023 8:00 AM ET Company Participants Yijing Brentano - SVP of Strategy, Corporate Development and IR Phillip Eyler - President and Chief Executive Officer Matteo Anversa - Executive Vice President of Finance, Chief Financial Officer and Treasurer Conference Call Participants Matt Koranda - ROTH MKM Operator Greetings, and welcome to the Gentherm First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only ...
Gentherm(THRM) - 2023 Q1 - Quarterly Report
2023-04-27 20:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-21810 GENTHERM INCORPORATED (Exact name of registrant as specified in its charter) Michigan 95-4318554 (State or other jurisdic ...
Gentherm(THRM) - 2022 Q4 - Annual Report
2023-02-24 22:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022 or ☐ Transition report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to . Commission file number 0-21810 GENTHERM INCORPORATED (Exact name of registrant as specified in its charter) | Michigan | | 95-4318554 | | --- | --- | --- | | ...
Gentherm(THRM) - 2022 Q4 - Earnings Call Transcript
2023-02-22 19:38
Gentherm Incorporated (NASDAQ:THRM) Q4 2022 Earnings Conference Call February 22, 2023 8:00 AM ET Company Participants Yijing Brentano - SVP of Strategy, Corporate Development and IR Phil Eyler - President and CEO Matteo Anversa - CFO Conference Call Participants Luke Junk - Baird Matt Koranda - Roth Ryan Sigdahl - Craig-Hallum Glenn Chin - Seaport Research Partners Operator Greetings, and welcome to the Gentherm Fourth Quarter and Year End 2022 Earnings Conference Call and Strategy Update. At this time, al ...
Gentherm(THRM) - 2022 Q3 - Earnings Call Transcript
2022-11-02 16:38
Financial Data and Key Metrics Changes - The company achieved the highest quarterly revenue in its history on an organic basis, with a year-over-year growth of 37% or 44% excluding foreign currency translation [8][9] - Product revenues increased by 37% compared to the same period last year, with automotive revenues reaching $322 million, a 38% increase year-over-year [26][27] - Gross margin rate for the third quarter was 24.1%, down from 28.5% in the prior year, primarily due to inflation in wages, materials, and freight costs [30][31] - Adjusted diluted earnings per share increased to $0.70 from $0.51 in the third quarter of the previous year [35] Business Line Data and Key Metrics Changes - Automotive revenues increased by 29% year-over-year when adjusted for acquisitions and foreign currency translation, outperforming light vehicle production by nearly 300 basis points [9][26] - Medical revenue grew 4% year-over-year, primarily driven by the acquisition of Dacheng Medical, but declined 8% when excluding this contribution and foreign exchange effects [21][29] Market Data and Key Metrics Changes - The company launched automotive solutions on 18 different vehicles across 12 OEMs, including major brands like BMW, General Motors, and Toyota [13] - The company secured $430 million in automotive awards during the third quarter, indicating strong demand for its products [16] Company Strategy and Development Direction - The company is focused on integrating the acquired businesses of Alfmeier and Dacheng Medical to enhance its value proposition in both automotive and medical sectors [8][9] - The company aims to leverage combined technologies to offer more compelling solutions, particularly in the growing electric vehicle market [20][18] Management's Comments on Operating Environment and Future Outlook - Management acknowledged ongoing challenges such as material and labor cost inflation, semiconductor shortages, and supply chain issues, but expressed confidence in achieving cost synergy goals starting in 2023 [12][24] - The company expects inflationary pressures and supply chain challenges to persist, but remains focused on innovation, execution, and cost management to deliver long-term growth [24][75] Other Important Information - The company has entered the equipment rental market to address hospitals' capital equipment needs, which is a strategic move given the financial pressures faced by healthcare institutions [22] - The company maintains its full-year 2022 guidance for product revenues in the range of $1.15 billion to $1.25 billion [37] Q&A Session Summary Question: Can you provide a breakdown of the award environment and the pipeline for combined thermal and pneumatic awards? - Management noted that thermal awards were significantly higher than pneumatic awards and expressed excitement about the growing interest in combined awards from several customers [41] Question: What factors contributed to the lower level of outperformance relative to production? - Management highlighted unique headwinds, including a tough comparison to the previous year and challenges in the non-automotive electronics business, which affected overall performance [44][45] Question: Can you elaborate on the gross margin pressures and the impact of acquisitions? - Management detailed that inflation in materials and wages, along with foreign exchange impacts, were significant headwinds, while higher sales volume and cost recoveries provided some offset [46][48] Question: What is the outlook for supply chain issues and OEM production schedules? - Management indicated that while improvements have been seen, supply chain visibility remains limited, and volatility continues to affect OEM production schedules [63][65] Question: How is the competitive environment evolving? - Management reported a high win rate in core business and noted strengthening relationships with key customers, indicating a positive competitive position [66][68] Question: What is the pipeline for climate sense technology and its integration with OEMs? - Management expressed excitement about ongoing projects and the potential for climate sense technology to enhance vehicle performance and efficiency, although integration requires significant lead time [72][73]
Gentherm(THRM) - 2022 Q2 - Quarterly Report
2022-08-02 21:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-21810 GENTHERM INCORPORATED (Exact name of registrant as specified in its charter) Michigan 95-4318554 (State or other jurisdict ...
Gentherm(THRM) - 2022 Q1 - Quarterly Report
2022-05-04 19:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-21810 GENTHERM INCORPORATED (Exact name of registrant as specified in its charter) Michigan 95-4318554 (State or other jurisdic ...
Gentherm(THRM) - 2021 Q4 - Annual Report
2022-02-17 21:45
Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2021 or UNITED STATES SECURITIES AND EXCHANGE COMMISSION GENTHERM INCORPORATED (Exact name of registrant as specified in its charter) Michigan 95-4318554 (State or other jurisdiction of incorporation or organization) 21680 Haggerty Road, Northville, MI 48167 (I.R.S. Employer Identification No.) (Address of principal executive offices) (Zip ...
Gentherm(THRM) - 2021 Q3 - Quarterly Report
2021-10-29 19:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 0-21810 GENTHERM INCORPORATED (Exact name of registrant as specified in its charter) Michigan 95-4318554 (State or other juri ...